Cargando…
Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization
BACKGROUND AND THE PURPOSE OF THE STUDY: Domperidone (DOM) is a dopamine- receptor (D(2)) antagonist, which is widely used in the treatment of motion-sickness. The pharmacokinetic parameters make DOM a suitable candidate for transdermal delivery. The purpose of the present investigation was to devel...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304359/ https://www.ncbi.nlm.nih.gov/pubmed/22615620 |
_version_ | 1782226885944541184 |
---|---|
author | Madishetti, S.K. Palem, C.R. Gannu, R. Thatipamula, R.P. Panakanti, P.K. Yamsani, M.R. |
author_facet | Madishetti, S.K. Palem, C.R. Gannu, R. Thatipamula, R.P. Panakanti, P.K. Yamsani, M.R. |
author_sort | Madishetti, S.K. |
collection | PubMed |
description | BACKGROUND AND THE PURPOSE OF THE STUDY: Domperidone (DOM) is a dopamine- receptor (D(2)) antagonist, which is widely used in the treatment of motion-sickness. The pharmacokinetic parameters make DOM a suitable candidate for transdermal delivery. The purpose of the present investigation was to develop transdermal delivery systems for DOM and to evaluate their physicochemical characteristics, in vitro release an ex vivo permeation through rat abdominal skin and their mechanical properties. METHODS: Bilayered matrix type transdermal drug delivery systems (TDDS) of DOM were prepared by film casting technique using hydroxypropyl methyl cellulose as primary and Eudragit RL 100 as secondary layers. Brij-35 was incorporated as a solubilizer, d-limonene and propylene glycol were employed as permeation enhancer and plasticizer respectively. The prepared TDDS were extensively evaluated for in vitro release, moisture absorption, moisture content, water vapor transmission, ex vivo permeation through rat abdominal skin, mechanical properties and stability studies. The physicochemical interaction between DOM and polymers were investigated by Differential Scanning Calorimetry (DSC) and Fourier Transform Infrared Spectroscopy (FTIR). RESULTS: All the formulations exhibited satisfactory physicochemical and mechanical characteristics. The optimized formulation F6 showed maximum cumulative percentage of drug release (90.7%), permeation (6806.64 µg) in 24 hrs, flux (86.02 µg /hr/cm(2)) and permeation coefficient of 0.86x10(−2) cm/hr. Values of tensile strength (4.34 kg/mm(2)) and elastic modulus (5.89 kg/cm(2)) revealed that formulation F6 was strong but not brittle. DSC and FTIR studies showed no evidence of interaction between the drug and polymers. A shelf life of 2 years is predicted for the TDDS. CONCLUSIONS: Domperidone bilayered matrix type transdermal therapeutic systems could be prepared with the required flux and suitable mechanical properties. |
format | Online Article Text |
id | pubmed-3304359 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-33043592012-05-21 Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization Madishetti, S.K. Palem, C.R. Gannu, R. Thatipamula, R.P. Panakanti, P.K. Yamsani, M.R. Daru Original Article BACKGROUND AND THE PURPOSE OF THE STUDY: Domperidone (DOM) is a dopamine- receptor (D(2)) antagonist, which is widely used in the treatment of motion-sickness. The pharmacokinetic parameters make DOM a suitable candidate for transdermal delivery. The purpose of the present investigation was to develop transdermal delivery systems for DOM and to evaluate their physicochemical characteristics, in vitro release an ex vivo permeation through rat abdominal skin and their mechanical properties. METHODS: Bilayered matrix type transdermal drug delivery systems (TDDS) of DOM were prepared by film casting technique using hydroxypropyl methyl cellulose as primary and Eudragit RL 100 as secondary layers. Brij-35 was incorporated as a solubilizer, d-limonene and propylene glycol were employed as permeation enhancer and plasticizer respectively. The prepared TDDS were extensively evaluated for in vitro release, moisture absorption, moisture content, water vapor transmission, ex vivo permeation through rat abdominal skin, mechanical properties and stability studies. The physicochemical interaction between DOM and polymers were investigated by Differential Scanning Calorimetry (DSC) and Fourier Transform Infrared Spectroscopy (FTIR). RESULTS: All the formulations exhibited satisfactory physicochemical and mechanical characteristics. The optimized formulation F6 showed maximum cumulative percentage of drug release (90.7%), permeation (6806.64 µg) in 24 hrs, flux (86.02 µg /hr/cm(2)) and permeation coefficient of 0.86x10(−2) cm/hr. Values of tensile strength (4.34 kg/mm(2)) and elastic modulus (5.89 kg/cm(2)) revealed that formulation F6 was strong but not brittle. DSC and FTIR studies showed no evidence of interaction between the drug and polymers. A shelf life of 2 years is predicted for the TDDS. CONCLUSIONS: Domperidone bilayered matrix type transdermal therapeutic systems could be prepared with the required flux and suitable mechanical properties. Tehran University of Medical Sciences 2010 /pmc/articles/PMC3304359/ /pubmed/22615620 Text en © 2010 Tehran University of Medical Sciences http://creativecommons.org/licenses/by/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Original Article Madishetti, S.K. Palem, C.R. Gannu, R. Thatipamula, R.P. Panakanti, P.K. Yamsani, M.R. Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization |
title | Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization |
title_full | Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization |
title_fullStr | Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization |
title_full_unstemmed | Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization |
title_short | Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization |
title_sort | development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304359/ https://www.ncbi.nlm.nih.gov/pubmed/22615620 |
work_keys_str_mv | AT madishettisk developmentofdomperidonebilayeredmatrixtypetransdermalpatchesphysicochemicalinvitroandexvivocharacterization AT palemcr developmentofdomperidonebilayeredmatrixtypetransdermalpatchesphysicochemicalinvitroandexvivocharacterization AT gannur developmentofdomperidonebilayeredmatrixtypetransdermalpatchesphysicochemicalinvitroandexvivocharacterization AT thatipamularp developmentofdomperidonebilayeredmatrixtypetransdermalpatchesphysicochemicalinvitroandexvivocharacterization AT panakantipk developmentofdomperidonebilayeredmatrixtypetransdermalpatchesphysicochemicalinvitroandexvivocharacterization AT yamsanimr developmentofdomperidonebilayeredmatrixtypetransdermalpatchesphysicochemicalinvitroandexvivocharacterization |